Scarica l'app Stockscreener
17.25
0.81%
-0.14
Dopo l'orario di chiusura:
17.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$17.39
Aprire:
$17.36
Volume 24 ore:
835.04K
Relative Volume:
1.10
Capitalizzazione di mercato:
$1.09B
Reddito:
$384.03M
Utile/perdita netta:
$38.65M
Rapporto P/E:
55.65
EPS:
0.31
Flusso di cassa netto:
$196.35M
1 W Prestazione:
-1.15%
1M Prestazione:
-10.81%
6M Prestazione:
-4.64%
1 anno Prestazione:
-14.65%
Intervallo 1D:
$17.10
$17.50
Intervallo di 1 settimana:
$16.52
$17.93
Portata 52W:
$16.52
$22.00
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Confronta INVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
17.25 | 1.05B | 384.03M | 38.65M | 196.35M | 0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Goldman | Sell |
| 2025-08-11 | Iniziato | Oppenheimer | Outperform |
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Earnings Beat and Shifting Stakes Might Change the Case for Investing in Innoviva (INVA) - simplywall.st
How strong is Innoviva Inc. stock revenue growthPortfolio Value Summary & Weekly Momentum Stock Picks - newser.com
Will Innoviva Inc. benefit from macro trendsTrade Entry Report & AI Forecasted Stock Moves - newser.com
What candlestick patterns are forming on Innoviva Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Analyzing recovery setups for Innoviva Inc. investorsQuarterly Trade Report & High Conviction Investment Ideas - newser.com
Innoviva stock hits 52-week low at 16.66 USD - Investing.com
Innoviva stock hits 52-week low at 16.66 USD By Investing.com - Investing.com Australia
Innoviva, Inc. $INVA Shares Sold by KLP Kapitalforvaltning AS - Defense World
What Fibonacci levels say about Innoviva Inc. rebound2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
What sentiment indicators say about Innoviva Inc. stockJuly 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com
Heatmap analysis for Innoviva Inc. and competitorsEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Innoviva (NASDAQ:INVA) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Technical analysis overview for Innoviva Inc. stockVolume Spike & Comprehensive Market Scan Insights - newser.com
Why Innoviva Inc. (HVE) stock appeals to dividend investors2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
New Strong Buy Stocks for October 10th - sharewise.com
Full technical analysis of Innoviva Inc. stock2025 Short Interest & Accurate Buy Signal Notifications - newser.com
What drives Innoviva Inc stock priceMoving Average Crossovers & Build a Smarter Portfolio Right Now - earlytimes.in
Weiss Ratings Reaffirms "Hold (C)" Rating for Innoviva (NASDAQ:INVA) - MarketBeat
QRG Capital Management Inc. Has $2.26 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critical Care Portfolio at IDWeek 2025 - BioSpace
Innoviva Specialty Therapeutics to Deliver Six Presentations from its Infectious Diseases and Critic - PharmiWeb.com
Is Innoviva, Inc.'s (NASDAQ:INVA) Recent Price Movement Underpinned By Its Weak Fundamentals? - 富途牛牛
Are Investors Undervaluing Innoviva (INVA) Right Now? - sharewise.com
Using Bollinger Bands to evaluate Innoviva Inc.Market Trend Summary & Daily Technical Forecast Reports - newser.com
Is now a turning point for Innoviva Inc.July 2025 Highlights & Smart Swing Trading Alerts - newser.com
Why Innoviva Inc. stock appeals to dividend seekersJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Innoviva Inc.Global Markets & Reliable Intraday Trade Plans - newser.com
How to interpret RSI for Innoviva Inc. stock2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com
Will earnings trigger a reversal in Innoviva Inc.Weekly Risk Summary & Weekly Momentum Picks - newser.com
Is this a good reentry point in Innoviva Inc.Insider Selling & Verified Swing Trading Watchlist - newser.com
Innoviva (NASDAQ:INVA) Stock Rating Lowered by Wall Street Zen - Defense World
Innoviva (NASDAQ:INVA) Lowered to Buy Rating by Wall Street Zen - MarketBeat
Brokerages Set Innoviva, Inc. (NASDAQ:INVA) PT at $37.60 - Defense World
Order flow analysis tools used on Innoviva Inc.Portfolio Value Summary & Stepwise Trade Execution Plans - newser.com
Innoviva (NASDAQ:INVA) Research Coverage Started at The Goldman Sachs Group - Defense World
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Innoviva Inc Azioni (INVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):